EUDAMED Milestone Reached – What It Means for Manufacturers and their processes with MDSS

May 28 notice

 

🚨 Today marks the first official EUDAMED deadline, reinforcing a critical shift.
EUDAMED registration is now mandatory for new devices entering the EU market.

This is not just a regulatory milestone — it directly impacts how manufacturers plan and execute market access under MDR/IVDR.

💡 How MDSS Supports You
We go beyond advisory — we integrate EUDAMED into your project execution:
  • EC REP services with built-in EUDAMED verification
  • End-to-end device registration readiness support
  • UDI and data structuring strategies

🚨 Important:
If MDSS acts as your European Authorised Representative (EC REP), EUDAMED verification will now be an integrated part of your onboarding and submission projects.

 

📌 What This Means in Practice
For new devices, EUDAMED is no longer optional:
  • Device registration in EUDAMED will be required
  • UDI and structured device data must be prepared upfront
  • Actor registration (SRN) must already be in place

 

⚠️ What We’re Seeing Across the Industry
Many companies are still underestimating:

  • The level of data structuring required
  • The link between UDI, EUDAMED, and technical documentation
  • The need for early preparation during product development

 

📣 Let’s Talk
📅 Book a meeting with our experts 🌐 Learn more about our services

EUDAMED is no longer “upcoming” — it is operational and shaping market access today.

Organizations that integrate it early into their processes will move faster, with fewer regulatory obstacles and stronger compliance confidence.